uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences.
Univ Klinikums Erlangen, Erlangen, Germany..
Univ Klinikums Erlangen, Erlangen, Germany..
Tokyo Med & Dent Univ, Tokyo, Japan..
Show others and affiliations
2016 (English)In: Journal of Clinical Oncology, ISSN 0732-183X, E-ISSN 1527-7755, Vol. 34, no 12, 1297-+ p.Article in journal, Editorial material (Other academic) Published
Resource type
Text
Place, publisher, year, edition, pages
2016. Vol. 34, no 12, 1297-+ p.
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-299185DOI: 10.1200/JCO.2015.65.3048ISI: 000374335100007PubMedID: 26903571OAI: oai:DiVA.org:uu-299185DiVA: diva2:949049
Available from: 2016-07-15 Created: 2016-07-15 Last updated: 2016-07-15Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Glimelius, Bengt
By organisation
Department of Surgical SciencesExperimental and Clinical Oncology
In the same journal
Journal of Clinical Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 288 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf